Cart
sales@molnova.com
Tricyclazole
CAS No. 41814-78-2
Tricyclazole( Tricyclazol )
Catalog No. M20584 CAS No. 41814-78-2
Tricyclazole is a pentaketide-derived melanin biosynthesis inhibitor and a unique fungicide for control of Pyricularia oryzae on rice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 50MG | 29 | In Stock |
|
| 100MG | 38 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 83 | In Stock |
|
| 1G | 120 | In Stock |
|
Biological Information
-
Product NameTricyclazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionTricyclazole is a pentaketide-derived melanin biosynthesis inhibitor and a unique fungicide for control of Pyricularia oryzae on rice.
-
DescriptionTricyclazole is a pentaketide-derived melanin biosynthesis inhibitor and a unique fungicide for control of Pyricularia oryzae on rice.
-
In Vitro——
-
In Vivo——
-
SynonymsTricyclazol
-
PathwayOthers
-
TargetOther Targets
-
Recptorpentaketide-derived melanin biosynthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41814-78-2
-
Formula Weight189.24
-
Molecular FormulaC9H7N3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (660.54 mM)
-
SMILESCc1cccc2sc3nncn3c12
-
Chemical Name124-Triazolo(34-b)benzothiazole 5-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lazarovits G Stoessl A . Tricyclazole induces melanin shunt products and inhibits altersolanol a accumulation by Alternaria solani[J]. Pesticide Biochemistry & Physiology 1988 31(1):36-45.
molnova catalog
related products
-
Thiopental sodium
Thiopental sodium (DEA controlled substance) is administered intravenously for the production of complete anesthesia of short duration or for the induction of general anesthesia. It is also used for the control of convulsive states and for hypnosis. It has been used to reduce increased intracranial pressure.
-
Koumine
Koumine has antineoplastic effect, may be a future breast cancer chemotherapeutic agent.
-
Vibostolimab
Vibostolimab is a monoclonal antibody against T cell immune proteins and the ITIM domain.
